What is it?
Interventional Cardiology is a subspecialty of cardiology. Interventional Cardiology uses specialized imaging and other diagnostic techniques to evaluate blood flow and pressure in the coronary arteries and chambers of the heart.
Interventional Cardiology procedures involve a non-surgical, invasive field for the treatment of coronary heart disease by using a catheter (tube) to access the coronary circulation and blood filled chambers of the heart.
The main advantage of this approach is that scarring, pain and long post surgery recovery is avoided.
Our interventional cardiology service includes percutaneous coronary interventions, closure of congenital intracardiac shunts, dilatation of narrowed heart valves, as well as peripheral interventions.As a major tertiary healthcare institution, we specialise in complex procedures which have become viable alternatives to open heart surgeries in selected patients.
We perform more than 1,900 diagnostic and 1,400 coronary, peripheral, valvuloplasty and congenital interventional procedures yearly.
A procedural volume has increased steadily in the last decade. In addition, the complexity of procedures has also increased and we now not infrequently embark in procedures for patients deemed to be at too high surgical risk. To improve patient comfort and minimize procedural complications, we have also moved towards using the radial artery as access site and performing procedures with smaller catheters.
In addition, we also embark on a variety of vascular interventional procedures that are not specific to the coronary arteries. These include renal and carotid artery stenting, device closure for patent foramen ovale and atrial septal defects, as well as peripheral intervention for disabling claudication or critical limb ischemia.
Our cardiac catheterisation laboratory is host to 4 interventional fellows each year. These fellows are an international mix from China, Philippines, Indonesia, and Myanmar. Some of our previous fellows are currently directors in their own laboratories and we continue to communicate closely with them, thus fostering a regional alliance.
We are also active in research and have published a number of studies in peer-reviewed journals. Our current research interests include the evaluation of a novel coated stent that promotes endothelialisation in patients with heart attacks. Plans are also underway to begin first-in-man trials evaluating new stents and drugs.
Back to Top